Protein kinase PKR mediates the apoptosis induction and growth restriction phenotypes of C protein-deficient measles virus

Journal of Virology

Volumn 83, Issue 2, 2009, Pages 961-968

  Toth, Ann M ^a   Devaux, Patricia ^b   Cattaneo, Roberto ^b   Samuel, Charles E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; DOUBLE STRANDED RNA; INITIATION FACTOR 2ALPHA; PROTEIN C; PROTEIN KINASE R; PROTEINASE; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; HELA CELL; HUMAN; HUMAN CELL; KNOCKOUT GENE; MEASLES VIRUS; MEDIATOR; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; UPREGULATION; VIROGENESIS; VIRUS INDUCTION; VIRUS INHIBITION; VIRUS REPLICATION; WILD TYPE;

ANIMALS; APOPTOSIS; CERCOPITHECUS AETHIOPS; EIF-2 KINASE; EUKARYOTIC INITIATION FACTOR-2; GENE DELETION; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HELA CELLS; HUMANS; MEASLES VIRUS; PHOSPHORYLATION; VERO CELLS; VIRAL NONSTRUCTURAL PROTEINS;

EUKARYOTA; MEASLES VIRUS;

EID: 58149487692     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01669-08     Document Type: Article

References (62)

1. Andrejeva, J., K. S. Childs, D. F. Young, T. S. Carlos, N. Stock, S. Goodbourn, and R. E. Randall. 2004. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN--β promoter. Proc. Natl. Acad. Sci. USA 101:17264-17269.
2. Balachandran, S., P. C. Roberts, T. Kipperman, K. N. Bhalla, R. W. Compans, D. R. Archer, and G. N. Barber. 2000. Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/caspase-8 death signaling pathway. J. Virol. 74:1513-1523.
3. Bankamp, B., J. Wilson, W. J. Bellini, and P. A. Rota. 2005. Identification of naturally occurring amino acid variations that affect the ability of the measles virus C protein to regulate genome replication and transcription. Virology 336:120-129.
4. Bellini, W. J., G. Englund, S. Rozenblatt, H. Arnheiter, and C. D. Richardson. 1985. Measles virus P gene codes for two proteins. J. Virol. 53:908-919.
5. Bolt, G., and I. R. Pedersen. 1998. The role of subtilisin-like proprotein convertases for cleavage of the measles virus fusion glycoprotein in different cell types. Virology 252:387-398.
6. Bonnet, M. C., R. Weil, E. Dam, A. G. Hovanessian, and E. F. Meurs. 2000. PKR stimulates NF-κB irrespective of its kinase function by interacting with the IκB kinase complex. Mol. Cell. Biol. 20:4532-4542.
7. Caignard, G., M. Guerbois, J.-L. Labernardière, Y. Jacob, L. M. Jones, F. Wild, F. Tangy, and P.-O. Vidalain. 2007. Measles virus V protein blocks Jak1-mediated phosphorylation of STAT1 to escape IFN-α/β- signaling. Virology 368:351-362.
8. Cathomen, T., H. Y. Naim, and R. Cattaneo. 1998. Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. J. Virol. 72:1224-1234.
9. Cattaneo, R., K. Kaelin, K. Baczko, and M. A. Billeter. 1989. Measles virus editing provides an additional cysteine-rich protein. Cell 56:759-764.
10. Centers for Disease Control. 2008. Measles - United States, January 1-April 25, 2008. MMWR Morb. Mort. Wkly. Rep. 57:494-498.
11. Chang, H. W., and B. L. Jacobs. 1993. Identification of a conserved motif that is necessary for binding of the vaccinia virus E3L gene-products to double-stranded-RNA. Virology 194:537-547.
12. Chang, H. W., L. H. Uribe, and B. L. Jacobs. 1995. Rescue of vaccinia virus lacking the E3L gene by mutants of E3L. J. Virol. 69:6605-6608.
13. Childs, K., N. Stock, C. Ross, J. Andrejeva, L. Hilton, M. Skinner, R. Randall, and S. Goodbourn. 2007. Mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 359:190-200.
14. Cruz, C. D., H. Palosaari, J.-P. Parisien, P. Devaux, R. Cattaneo, T. Ouchi, and C. M. Horvath. 2006. Measles virus V protein inhibits p53 family member p73. J. Virol. 80:5644-5650.
15. Der, S. D., Y.-L. Yang, C. Weissmann, and B. R. G. Williams. 1997. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc. Natl. Acad. Sci. USA 94:3279-3283.
16. Devaux, P., and R. Cattaneo. 2004. Measles virus phosphoprotein gene products: conformational flexibility of the P/V protein amino-terminal domain and C protein infectivity factor function. J. Virol. 78:11632- 11640.
17. Devaux, P., G. Hodge, M. B. McChesney, and R. Cattaneo. 2008. Attenuation of V- or C-defective measles viruses: infection control by the inflammatory and interferon responses of rhesus monkeys. J. Virol. 82:5359-5367.
18. Devaux, P., V. von Messling, W. Songsungthong, C. Springfeld, and R. Cattaneo. 2007. Tyrosine 110 in the measles virus phosphoprotein is required to block STAT1 phosphorylation. Virology 360:72-83.
19. Dhib-Jalbut, S., J. Xia, H. Rangaviggula, Y.-Y. Fang, and T. Lee. 1999. Failure of measles virus to activate nuclear factor-κB in neuronal cells: implications on the immune response to viral infections in the central nervous system. J. Immunol. 162:4024-4029.
20. Donze, O., J. Deng, J. Curran, R. Sladek, D. Picard, and N. Sonenberg. 2004. The protein kinase PKR: a molecular clock that sequentially activates survival and death programs. EMBO J. 23:564-571.
21. Escoffier, C., S. Manie, S. Vincent, C. P. Muller, M. Billeter, and D. Gerlier. 1999. Nonstructural C protein is required for efficient measles virus replication in human peripheral blood cells. J. Virol. 73:1695-1698.
22. Esolen, L., S. Park, J. Hardwick, and D. Griffin. 1995. Apoptosis as a cause of death in measles virus-infected cells. J. Virol. 69:3955-3958.
23. Fontana, J. M., B. Bankamp, W. J. Bellini, and P. A. Rota. 2008. Regulation of interferon signaling by the C and V proteins from attenuated and wildtype strains of measles virus. Virology 374:71-81.
24. Gainey, M. D., P. J. Dillon, K. M. Clark, M. J. Manuse, and G. D. Parks. 2008. Paramyxovirus-induced shutoff of host and viral protein synthesis: role of the P and V proteins in limiting PKR activation. J. Virol. 82:828-839.
25. Goh, K. C., M. J. deVeer, and B. R. G. Williams. 2000. The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin. EMBO J. 19:4292-4297.
26. Gotoh, B., T. Komatsu, K. Takeuchi, and J. Yokoo. 2001. Paramyxovirus accessory proteins as interferon antagonists. Microbiol. Immunol. 45:787-800.
27. Griffin, D. 2007. Measles virus, p. 1551-1585. In P. Howley, D. Griffin, R. Lamb, M. Martin, B. Roizman, and S. Straus (ed.), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
28. Haller, O., G. Kochs, and F. Weber. 2006. The interferon response circuit: induction and suppression by pathogenic viruses. Virology 344:119-130.
29. Jansen, V. A. A., N. Stollenwerk, H. J. Jensen, M. E. Ramsay, W. J. Edmunds, and C. J. Rhodes. 2003. Measles outbreaks in a population with declining vaccine uptake. Science 301:804.
30. Karber, G. 1931. Beitrag zur kollektiven behandlung pharmakologischer reihenversuche. Naunyn-Schmiedeberg's Arch. Pharmacol. 162:480-483.
31. Kumar, A., Y. L. Yang, V. Flati, S. Der, S. Kadereit, A. Deb, J. Haque, L. Reis, C. Weissmann, and B. R. G. Williams. 1997. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-κB. EMBO J. 16:406-416.
32. Liston, P., and D. J. Briedis. 1994. Measles virus V protein binds zinc. Virology 198:399-404.
33. Martin, U., N. Jarasch, M. Nestler, A. Rassmann, T. Munder, S. Seitz, R. Zell, P. Wutzler, and A. Henke. 2007. Antiviral effects of pan-caspase inhibitors on the replication of coxsackievirus B3. Apoptosis 12:525-533.
34. McCormack, S. J., D. C. Thomis, and C. E. Samuel. 1992. Mechanism of interferon action: identification of a RNA binding domain within the Nterminal region of the human RNA-dependent p1/eIF-2α protein kinase. Virology 188:47-56.
35. Nakatsu, Y., M. Takeda, S. Ohno, R. Koga, and Y. Yanagi. 2006. Translational inhibition and increased interferon induction in cells infected with C protein-deficient measles virus. J. Virol. 80:11861-11867.
36. Nakatsu, Y., M. Takeda, S. Ohno, Y. Shirogane, M. Iwasaki, and Y. Yanagi. 2008. Measles virus circumvents the host interferon response by different actions of the C and V proteins. J. Virol. 82:8296-8306.
37. Navaratnarajah, C. K., V. H. L. Leonard, and R. Cattaneo. 2009. Measles virus: glycoprotein complex assembly, receptor attachment, and cell entry, p. 59-76. In D. E. Griffin and M. B. A. Oldstone (ed.), Measles history and basic biology, vol. 329. Springer-Verlag, New York, NY.
38. Ohno, S., N. Ono, M. Takeda, K. Takeuchi, and Y. Yanagi. 2004. Dissection of measles virus V protein in relation to its ability to block alpha/beta interferon signal transduction. J. Gen. Virol. 85:2991-2999.
39. Palosaari, H., J.-P. Parisien, J. J. Rodriguez, C. M. Ulane, and C. M. Horvath. 2003. STAT protein interference and suppression of cytokine signal transduction by measles virus V protein. J. Virol. 77:7635-7644.
40. Pathak, V. K., D. Schindler, and J. W. Hershey. 1988. Generation of a mutant form of protein synthesis initiation factor eIF-2 lacking the site of phosphorylation by eIF-2 kinases. Mol. Cell. Biol. 8:993-995.
41. Patterson, J. B., D. Thomas, H. Lewicki, M. A. Billeter, and M. B. A. Oldstone. 2000. V and C proteins of measles virus function as virulence factors in vivo. Virology 267:80-89.
42. Radecke, F., and M. A. Billeter. 1996. The nonstructural C protein is not essential for multiplication of Edmonston B strain measles virus in cultured cells. Virology 217:418-421.
43. Ramachandran, A., J.-P. Parisien, and C. M. Horvath. 2008. STAT2 is a primary target for measles virus V protein-mediated IFN-α/β- signaling inhibition. J. Virol. 82:8330-8338.
44. Randall, R. E., and S. Goodbourn. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89:1-47.
45. Reutter, G. L., C. Cortese-Grogan, J. Wilson, and S. A. Moyer. 2001. Mutations in the measles virus C protein that up regulate viral RNA synthesis. Virology 285:100-109.
46. Samuel, C. E. 1979. Mechanism of interferon action: phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase. Proc. Natl. Acad. Sci. USA 76:600-604.
47. Samuel, C. E. 1993. The eIF-2 alpha protein kinases, regulators of translation in eukaryotes from yeasts to humans. J. Biol. Chem. 268:7603-7606.
48. Samuel, C. E. 2001. Antiviral actions of interferons. Clin. Microbiol. Rev. 14:778-809.
49. Schneider, H., K. Kaelin, and M. A. Billeter. 1997. Recombinant measles viruses defective for RNA editing and V protein synthesis are viable in cultured cells. Virology 227:314-322.
50. Shaffer, J. A., W. J. Bellini, and P. A. Rota. 2003. The C protein of measles virus inhibits the type I interferon response. Virology 315:389-397.
51. Takeuchi, K., S.-I. Kadota, M. Takeda, N. Miyajima, and K. Nagata. 2003. Measles virus V protein blocks interferon IFN-α/β- but not IFN- signaling by inhibiting STAT1 and STAT2 phosphorylation. FEBS Lett. 545:177-182.
52. Takeuchi, K., T. Komatsu, Y. Kitagawa, K. Sada, and B. Gotoh. 2008. Sendai virus C protein plays a role in restricting PKR activation by limiting the generation of intracellular double-stranded RNA. J. Virol. 82:10102-10110.
53. Takeuchi, K., M. Takeda, N. Miyajima, Y. Ami, N. Nagata, Y. Suzaki, J. Shahnewaz, S.-I. Kadota, and K. Nagata. 2005. Stringent requirement for the C protein of wild-type measles virus for growth both in vitro and in macaques. J. Virol. 79:7838-7844.
54. Tanaka, H., and C. Samuel. 1994. Mechanism of interferon action: structure of the mouse PKR gene encoding the interferon-inducible RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA 91:7995-7999.
55. Tober, C., M. Seufert, H. Schneider, M. A. Billeter, I. C. D. Johnston, S. Niewiesk, V. ter Meulen, and S. Schneider-Schaulies. 1998. Expression of measles virus V protein is associated with pathogenicity and control of viral RNA synthesis. J. Virol. 72:8124-8132.
56. Toth, A. M., P. Zhang, S. Das, C. X. George, and C. E. Samuel. 2006. Interferon action and the double-stranded RNA-dependent enzymes ADAR1 adenosine deaminase and PKR protein kinase. Prog. Nucleic Acid Res. Mol. Biol. 81:369-434.
57. Wardrop, E. A., and D. J. Briedis. 1991. Characterization of V protein in measles virus-infected cells. J. Virol. 65:3421-3428.
58. Williams, B. R. G. 2001. Signal integration via PKR. Sci. STKE 2001:re2.
59. World Health Organization. 2008. Measles. World Health Organization, Geneva, Switzerland.
60. Yokota, S.-I., H. Saito, T. Kubota, N. Yokosawa, K.-I. Amano, and N. Fujii. 2003. Measles virus suppresses interferon-α signaling pathway: suppression of Jak1 phosphorylation and association of viral accessory proteins, C and V, with interferon-α receptor complex. Virology 306:135-146.
61. Zhang, P., B. L. Jacobs, and C. E. Samuel. 2008. Loss of protein kinase PKR expression in human HeLa cells complements the vaccinia virus E3L deletion mutant phenotype by restoration of viral protein synthesis. J. Virol. 82:840-848.
62. Zhang, P., and C. E. Samuel. 2007. Protein kinase PKR plays a stimulus- and virus-dependent role in apoptotic death and virus multiplication in human cells. J. Virol. 81:8192-8200.